Difficulty: Medium
Average Score: 89%
Practice
A 33-year-old man with advanced Crohn disease is treated with multiagent therapy including 6-mercaptopurine. On his most recent CT scan, there is evidence of disease progression to include the entire ileum and right colon. What is the most likely explanation for these findings?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Decreased metabolism to thiouric acid. 6-mercaptopurine (6-MP) is a prodrug that undergoes metabolism to active metabolites, one of which is thiouric acid. In patients with decreased metabolism to thiouric acid, higher levels of 6-MP metabolites accumulate, leading to increased toxicity and potentially disease progression in conditions like Crohn's disease.
Option A) Ability to transform 6-MP to a nucleotide is incorrect because this transformation is essential for the drug's therapeutic effects, not disease progression.
Option B) Decreased metabolism to other metabolites is incorrect as the issue lies specifically with the metabolism to thiouric acid, not other metabolites.
Option D) Increased dephosphorylation is incorrect as increased dephosphorylation would lead to decreased levels of active metabolites, which would not explain disease progression.
From an educational perspective, understanding the metabolism of drugs like 6-MP is crucial for pharmacology students and healthcare professionals to optimize treatment outcomes and minimize adverse effects in patients with conditions like Crohn's disease. This question highlights the importance of drug metabolism variations and their impact on therapeutic efficacy and patient outcomes.
Option A) Ability to transform 6-MP to a nucleotide is incorrect because this transformation is essential for the drug's therapeutic effects, not disease progression.
Option B) Decreased metabolism to other metabolites is incorrect as the issue lies specifically with the metabolism to thiouric acid, not other metabolites.
Option D) Increased dephosphorylation is incorrect as increased dephosphorylation would lead to decreased levels of active metabolites, which would not explain disease progression.
From an educational perspective, understanding the metabolism of drugs like 6-MP is crucial for pharmacology students and healthcare professionals to optimize treatment outcomes and minimize adverse effects in patients with conditions like Crohn's disease. This question highlights the importance of drug metabolism variations and their impact on therapeutic efficacy and patient outcomes.